91 related articles for article (PubMed ID: 9691165)
1. Effect of cyclosporine A on the gastrointestinal absorption of acyclovir in neonatal and adult rats.
Mizuno N; Takagi C; Yamamoto N; Takahashi K
Biol Neonate; 1998; 74(3):243-52. PubMed ID: 9691165
[TBL] [Abstract][Full Text] [Related]
2. Effect of age on the gastrointestinal absorption of acyclovir in rats.
Fujioka Y; Mizuno N; Morita E; Motozono H; Takahashi K; Yamanaka Y; Shinkuma D
J Pharm Pharmacol; 1991 Jul; 43(7):465-9. PubMed ID: 1682458
[TBL] [Abstract][Full Text] [Related]
3. Toxic effect of concomitant administration of cyclosporin A and acyclovir on renal function and morphology in rats.
Hannemann J; Wunderle W; Yousif T; Krüger S; Baumann K
Arch Toxicol; 1997; 71(9):556-62. PubMed ID: 9285038
[TBL] [Abstract][Full Text] [Related]
4. Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide.
Cárcel-Trullols J; Torres-Molina F; Araico A; Saadeddin A; Peris JE
Cancer Chemother Pharmacol; 2004 Aug; 54(2):153-60. PubMed ID: 15114410
[TBL] [Abstract][Full Text] [Related]
5. Effect of atropine on gastrointestinal motility and the bioavailability of cyclosporine A in rats.
Quijano RF; Ohnishi N; Umeda K; Komada F; Iwakawa S; Okumura K
Drug Metab Dispos; 1993; 21(1):141-3. PubMed ID: 8095208
[TBL] [Abstract][Full Text] [Related]
6. Long-term levothyroxine treatment decreases the oral bioavailability of cyclosporin A by inducing P-glycoprotein in small intestine.
Jin M; Shimada T; Shintani M; Yokogawa K; Nomura M; Miyamoto K
Drug Metab Pharmacokinet; 2005 Oct; 20(5):324-30. PubMed ID: 16272749
[TBL] [Abstract][Full Text] [Related]
7. Rectal absorption of acyclovir in rats and improvement of absorption by triglyceride base.
Ogiso T; Iwaki M; Tanino T; Fujii J; Paku T
Biol Pharm Bull; 1993 Mar; 16(3):315-8. PubMed ID: 8364481
[TBL] [Abstract][Full Text] [Related]
8. Cyclosporine-loaded polycaprolactone nanoparticles: immunosuppression and nephrotoxicity in rats.
Varela MC; Guzmán M; Molpeceres J; del Rosario Aberturas M; Rodríguez-Puyol D; Rodríguez-Puyol M
Eur J Pharm Sci; 2001 Feb; 12(4):471-8. PubMed ID: 11231114
[TBL] [Abstract][Full Text] [Related]
9. Effect of streptozotocin-induced diabetes on cyclosporin A disposition in rats.
Ogata M; Iizuka Y; Murata R; Hikichi N
Biol Pharm Bull; 1996 Dec; 19(12):1586-90. PubMed ID: 8996644
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of a novel gastric mucoadhesive sustained-release acyclovir microsphere.
Liu H; Pan W; Ke P; Dong Y; Ji L
Drug Dev Ind Pharm; 2010 Sep; 36(9):1098-105. PubMed ID: 20545521
[TBL] [Abstract][Full Text] [Related]
11. A physiologically based pharmacokinetic model for valacyclovir established based on absolute expression quantity of hPEPT1 and its application.
Sun L; Wang C; Zhang Y
Eur J Pharm Sci; 2018 Oct; 123():560-568. PubMed ID: 30081070
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the contribution of the nasal cavity and gastrointestinal tract to drug absorption following nasal application to rats.
Furubayashi T; Kamaguchi A; Kawaharada K; Masaoka Y; Kataoka M; Yamashita S; Higashi Y; Sakane T
Biol Pharm Bull; 2007 Mar; 30(3):608-11. PubMed ID: 17329868
[TBL] [Abstract][Full Text] [Related]
13. Contributions of intestinal P-glycoprotein and CYP3A to oral bioavailability of cyclosporin A in mice treated with or without dexamethasone.
Jin M; Shimada T; Yokogawa K; Nomura M; Kato Y; Tsuji A; Miyamoto K
Int J Pharm; 2006 Feb; 309(1-2):81-6. PubMed ID: 16384676
[TBL] [Abstract][Full Text] [Related]
14. Effects of combination of cyclosporine with losartan or enalapril on kidney function in uremic rats.
Azzadin A; Małyszko J; Małyszko JS; Tankiewicz A; Myśliwiec M; Buczko W
Pol J Pharmacol; 2002; 54(5):469-73. PubMed ID: 12593533
[TBL] [Abstract][Full Text] [Related]
15. Effect of non-insulin dependent diabetes on cyclosporin A disposition in Goto-Kakizaki (GK) rats.
Ogata M; Uchimura T; Iizuka Y; Murata R; Suzuki S; Toyota T; Hikichi N
Biol Pharm Bull; 1997 Sep; 20(9):1026-9. PubMed ID: 9331992
[TBL] [Abstract][Full Text] [Related]
16. The Effect of P-Glycoprotein Inhibition and Activation on the Absorption and Serum Levels of Cyclosporine and Tacrolimus in Rats.
Yigitaslan S; Erol K; Cengelli C
Adv Clin Exp Med; 2016; 25(2):237-42. PubMed ID: 27627555
[TBL] [Abstract][Full Text] [Related]
17. Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats.
Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
J Pharm Pharmacol; 2004 Oct; 56(10):1259-66. PubMed ID: 15482640
[TBL] [Abstract][Full Text] [Related]
18. Effects of STZ-induced diabetes and its treatment with vanadyl sulphate on cyclosporine A-induced nephrotoxicity in rats.
Saad SY; Najjar TA
Arch Toxicol; 2005 Sep; 79(9):493-9. PubMed ID: 15940472
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary delivery of intratracheally instilled and aerosolized cyclosporine A to young and adult rats.
Taljanski W; Pierzynowski SG; Lundin PD; Westrom BR; Eirefelt S; Podlesny J; Dahlback M; Siwinska-Golebiowska H; Karlsson BW
Drug Metab Dispos; 1997 Aug; 25(8):917-20. PubMed ID: 9280398
[TBL] [Abstract][Full Text] [Related]
20. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability.
Tao Y; Lu Y; Sun Y; Gu B; Lu W; Pan J
Int J Pharm; 2009 Aug; 378(1-2):30-6. PubMed ID: 19465102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]